Busca-Arenzana C, Ortega-Gonzalez D, Diaz-Almiron M, Montes ML, et al. Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study. HIV Med 2024 May 15. doi: 10.1111/hiv.13659.
PMID: 38746980